Assenagon Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1M | Sell |
350,411
-770,522
| -69% | -$33.3M | 0.02% | 371 |
|
|
2025
Q1 | $38.8M | Buy |
1,120,933
+1,096,799
| +4,545% | +$37.9M | 0.06% | 231 |
|
|
2024
Q4 | $662K | Hold |
24,134
| – | – | ﹤0.01% | 1139 |
|
|
2024
Q3 | $614K | Sell |
24,134
-222,761
| -90% | -$5.67M | ﹤0.01% | 1182 |
|
|
2024
Q2 | $6.25M | Buy |
246,895
+239,900
| +3,430% | +$6.08M | 0.01% | 541 |
|
|
2024
Q1 | $216K | Sell |
6,995
-29,739
| -81% | -$920K | ﹤0.01% | 1295 |
|
|
2023
Q4 | $1.48M | Sell |
36,734
-4,024
| -10% | -$162K | ﹤0.01% | 983 |
|
|
2023
Q3 | $1.07M | Sell |
40,758
-110,204
| -73% | -$2.91M | ﹤0.01% | 999 |
|
|
2023
Q2 | $2.6M | Buy |
150,962
+17,438
| +13% | +$300K | 0.01% | 660 |
|
|
2023
Q1 | $2.21M | Sell |
133,524
-102,676
| -43% | -$1.7M | 0.01% | 781 |
|
|
2022
Q4 | $1.8M | Sell |
236,200
-863
| -0.4% | -$6.58K | 0.01% | 813 |
|
|
2022
Q3 | $2.36M | Sell |
237,063
-252,270
| -52% | -$2.51M | 0.01% | 635 |
|
|
2022
Q2 | $4.44M | Sell |
489,333
-745,544
| -60% | -$6.77M | 0.02% | 557 |
|
|
2022
Q1 | $12.5M | Buy |
1,234,877
+1,223,122
| +10,405% | +$12.4M | 0.03% | 289 |
|
|
2021
Q4 | $196K | Buy |
11,755
+3,686
| +46% | +$61.5K | ﹤0.01% | 1331 |
|
|
2021
Q3 | $378K | Buy |
+8,069
| New | +$378K | ﹤0.01% | 1069 |
|